News

Press & Publications

Could A Vaccine Protect Football Players From Concussions?

WIRED  |  February 2, 2018

United Neuroscience developing a drug designed to inoculate the brain against CTE


United Neuroscience Announces Development Plans for Vaccine to Prevent CTE

News Release  |  January 29, 2018

UNS announced plans for the development of a vaccine for the prevention of chronic traumatic encephalopathy (CTE)


United Neuroscience Featured On ABC News Radio

ABC News Radio  |  January 10, 2018

National Radio News Network Covers United Neuroscience Alzheimer’s Vaccine Program


Life-Saving Innovations On Display At JPMorgan Healthcare Conference

ABC 7 News  |  January 8, 2018

United Neuroscience Alzheimer’s Vaccine Program featured along with the Bill and Melinda Gates Foundation at JPMorgan Healthcare Conference 2018


Global Health: Partnerships Hold The Key

Pharmaceutical Executive  |  December 29, 2017

Amid a widening net of global health threats, alliances in research and response may be more crucial than ever


Brain Hacking: What Bill Gates And Other Tech Titans Want With Our Mind

NBC News  |  December 29, 2017

United Neuroscience Co-Founder, Lou Reese quoted in NBC News Segment looking at new technological approaches to tackling Alzheimer’s and other neurodegenerative diseases


United Neuroscience’s Mei Mei Hu Interviewed By MSNBC’s Ali Velshi

MSNBC  |  December 27, 2017

Alzheimer's disease treatments and United Neuroscience's plans for a vaccine on MSNBC


United Neuroscience’s Mei Mei Hu Interviewed by MSNBC’s Ali Velshi

MSNBC  |  December 27, 2017

Alzheimer's disease treatments, United Neuroscience's plans for a vaccine, and neurology research are among the topics discussed on 12/27/2017 at 3:50pm ET on MSNBC.


Ace Of BACE? Mechanism May Block AD Before Symptoms

BioWorld  |  November 6, 2017

Bioworld article heralding United Neuorscience’s endobody prospect in tackling Alzheimer’s Disease


As Alz Players Stand United, New A-Beta Bids Also To Fall?

BioWorld  |  November 3, 2017

Bioworld article recognizing the strides United Neuorscience’s endobody work has made in tackling Alzheimer’s Disease


United Neuroscience Presents Data For Phase 2 Active Vaccine Program UB-311 At The Clinical Trials On Alzheimer’s Disease 2017 Meeting

United Neuroscience News Release  |  November 1, 2017

United Neuroscience, a clinical stage biotechnology company dedicated to developing best-in-class therapies for Alzheimer's disease, neurodegenerative disorders and orphan indications in neurology, today announced analyses of data for UB-311, its novel synthetic peptide vaccine targeting beta amyloid (Aβ) in the treatment of AD


UB-311, A Novel UBITh® Amyloid β Peptide Vaccine For Mild Alzheimer’s Disease

Alzheimer's & Dementia: Translational Research & Clinical Interventions  |  June 15, 2017

The UBITh® platform can generate a high-precision molecular vaccine with high responder rate, strong on-target immunogenicity, and a potential of cognition improvement, which support UB-311 for active immunotherapy in early-to-mild AD patients currently enrolled in a phase-II trial


United Neuroscience Names Ajay Verma Chief Medical Officer

Alzheimer's & Dementia: Translational Research & Clinical Interventions  |  March 20, 2017

Xconomy article announcing the hire of Ajay Verma, formerly head of Neuroscience at Biogen, into the position of Chief Medical Officer